106 related articles for article (PubMed ID: 11034073)
1. 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes.
Wu GJ; Sinclair CS; Paape J; Ingle JN; Roche PC; James CD; Couch FJ
Cancer Res; 2000 Oct; 60(19):5371-5. PubMed ID: 11034073
[TBL] [Abstract][Full Text] [Related]
2. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.
Bärlund M; Monni O; Kononen J; Cornelison R; Torhorst J; Sauter G; Kallioniemi OLLI-P ; Kallioniemi A
Cancer Res; 2000 Oct; 60(19):5340-4. PubMed ID: 11034067
[TBL] [Abstract][Full Text] [Related]
3. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.
Couch FJ; Wang XY; Wu GJ; Qian J; Jenkins RB; James CD
Cancer Res; 1999 Apr; 59(7):1408-11. PubMed ID: 10197603
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors.
Wu G; Sinclair C; Hinson S; Ingle JN; Roche PC; Couch FJ
Cancer Res; 2001 Jul; 61(13):4951-5. PubMed ID: 11431322
[TBL] [Abstract][Full Text] [Related]
5. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
[TBL] [Abstract][Full Text] [Related]
6. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
[TBL] [Abstract][Full Text] [Related]
7. RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes.
Kao J; Pollack JR
Genes Chromosomes Cancer; 2006 Aug; 45(8):761-9. PubMed ID: 16708353
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis.
Zhao C; Yasui K; Lee CJ; Kurioka H; Hosokawa Y; Oka T; Inazawa J
Cancer; 2003 Jul; 98(1):18-23. PubMed ID: 12833450
[TBL] [Abstract][Full Text] [Related]
9. Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.
Bièche I; Tomasetto C; Régnier CH; Moog-Lutz C; Rio MC; Lidereau R
Cancer Res; 1996 Sep; 56(17):3886-90. PubMed ID: 8752152
[TBL] [Abstract][Full Text] [Related]
10. PS6K amplification characterizes a small subset of anaplastic meningiomas.
Cai DX; James CD; Scheithauer BW; Couch FJ; Perry A
Am J Clin Pathol; 2001 Feb; 115(2):213-8. PubMed ID: 11211609
[TBL] [Abstract][Full Text] [Related]
11. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.
Yao J; Weremowicz S; Feng B; Gentleman RC; Marks JR; Gelman R; Brennan C; Polyak K
Cancer Res; 2006 Apr; 66(8):4065-78. PubMed ID: 16618726
[TBL] [Abstract][Full Text] [Related]
12. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
[TBL] [Abstract][Full Text] [Related]
13. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
Jacobson KK; Morrison LE; Henderson BT; Blondin BA; Wilber KA; Legator MS; O'Hare A; Van Stedum SC; Proffitt JH; Seelig SA; Coon JS
Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells.
Erson AE; Niell BL; DeMers SK; Rouillard JM; Hanash SM; Petty EM
Neoplasia; 2001; 3(6):521-6. PubMed ID: 11774034
[TBL] [Abstract][Full Text] [Related]
15. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17.
Tomasetto C; Régnier C; Moog-Lutz C; Mattei MG; Chenard MP; Lidereau R; Basset P; Rio MC
Genomics; 1995 Aug; 28(3):367-76. PubMed ID: 7490069
[TBL] [Abstract][Full Text] [Related]
16. High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer.
Pärssinen J; Kuukasjärvi T; Karhu R; Kallioniemi A
Br J Cancer; 2007 Apr; 96(8):1258-64. PubMed ID: 17353917
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.
Dressman MA; Baras A; Malinowski R; Alvis LB; Kwon I; Walz TM; Polymeropoulos MH
Cancer Res; 2003 May; 63(9):2194-9. PubMed ID: 12727839
[TBL] [Abstract][Full Text] [Related]
18. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
19. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
[TBL] [Abstract][Full Text] [Related]
20. Impact of DNA amplification on gene expression patterns in breast cancer.
Hyman E; Kauraniemi P; Hautaniemi S; Wolf M; Mousses S; Rozenblum E; Ringnér M; Sauter G; Monni O; Elkahloun A; Kallioniemi OP; Kallioniemi A
Cancer Res; 2002 Nov; 62(21):6240-5. PubMed ID: 12414653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]